ITMN, ABT oritavancin manufacturing deal

Abbott (ABT) will provide bulk manufacturing for oritavancin, a semi-synthetic glycopeptide antibiotic from InterMune (ITMN) to treat gram-positive bacterial infections. ABT will be responsible for te...